{"id":"https://openalex.org/W2264183261","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.15587","title":"Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer: First results of a multicenter phase II trial (AGMT Gastric- 2","display_name":"Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer: First results of a multicenter phase II trial (AGMT Gastric- 2","publication_year":2008,"publication_date":"2008-05-20","ids":{"openalex":"https://openalex.org/W2264183261","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.15587","mag":"2264183261"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2008.26.15_suppl.15587","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.15587","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.15587","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019548616","display_name":"Ewald Woell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Woell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050976830","display_name":"R. Greil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Greil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061264691","display_name":"Wolfgang Eisterer","orcid":"https://orcid.org/0000-0003-1244-7275","observed_orcids":["https://orcid.org/0000-0003-1244-7275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Eisterer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067806282","display_name":"Michael Fridrik","orcid":"https://orcid.org/0000-0003-4073-4191","observed_orcids":["https://orcid.org/0000-0003-4073-4191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Fridrik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047025255","display_name":"Birgit Gr\u00fcnberger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Gr\u00fcnberger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028574419","display_name":"Klaus B. Gattringer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Gattringer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014659824","display_name":"Beate Mayrb\u00e4url","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Mayrb\u00e4url","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040272835","display_name":"Gudrun Russ","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Russ","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111846755","display_name":"Josef Thaler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Thaler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"15_suppl","first_page":"15587","last_page":"15587"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-gastric-cancer","display_name":"advanced gastric cancer","score":0.9670000076293945},{"id":"https://openalex.org/keywords/gastric-adenocarcinoma","display_name":"gastric adenocarcinoma","score":0.8640000224113464},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9739999771118164},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":1.0},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.6949999928474426},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/metastatic-gastric-cancer","display_name":"metastatic gastric cancer","score":0.6499999761581421},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.734000027179718},{"id":"https://openalex.org/keywords/sensory-neuropathy","display_name":"sensory neuropathy","score":0.6940000057220459},{"id":"https://openalex.org/keywords/acneiform-rash","display_name":"acneiform rash","score":0.8209999799728394},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.6430000066757202},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8080000281333923},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8600000143051147},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9739999771118164},{"id":"https://openalex.org/keywords/outpatient-chemotherapy","display_name":"outpatient chemotherapy","score":0.5809999704360962},{"id":"https://openalex.org/keywords/biweekly-dosing","display_name":"biweekly dosing","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.949987530708313},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.711016833782196},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6471174955368042},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5920121073722839},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.5908049941062927},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.5633223652839661},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5549443960189819},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5364649295806885},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5319433808326721},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5207167267799377},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4745044410228729},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.4463985562324524},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4161664843559265},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3817272186279297},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.37239354848861694},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2213858962059021},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0895414650440216}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2008.26.15_suppl.15587","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.15587","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.15587","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2150888371","https://openalex.org/W2598771431","https://openalex.org/W2285441557","https://openalex.org/W1912309936","https://openalex.org/W2248251446","https://openalex.org/W2240401165","https://openalex.org/W2157183678","https://openalex.org/W4246814051","https://openalex.org/W2241448556","https://openalex.org/W2134554417"],"abstract_inverted_index":{"15587":[0],"Background:":[1],"Survival":[2],"of":[3,35,48,55,169,180,237,256,271,285],"patients":[4,100,133,216,257],"(pts.)":[5],"suffering":[6],"from":[7],"gastric":[8,18,107],"cancer":[9,19],"is":[10,277],"still":[11],"poor":[12],"and":[13,37,42,50,78,91,109,156,176,194,210,233,273,279],"treatment":[14],"options":[15],"for":[16],"advanced":[17],"are":[20],"limited.":[21],"In":[22,58,96],"a":[23,51,71],"previous":[24,111],"phase":[25,61],"II":[26,62],"trial":[27,63],"we":[28,64],"could":[29],"show":[30],"that":[31],"an":[32,44],"outpatient":[33],"combination":[34,69,270],"oxaliplatin":[36,272],"irinotecan":[38,79,274],"was":[39,147,245,252],"well":[40],"tolerated":[41],"showed":[43],"objective":[45],"response":[46,148],"rate":[47],"58%":[49],"median":[52],"overall":[53,154],"survival":[54,155,159],"9.5":[56],"months.":[57],"this":[59,66],"multicenter":[60],"tested":[65],"chemotherapy":[67,113],"in":[68,199,203,207,212,235,239,254],"with":[70,85,101,275],"cetuximab.":[72],"Methods:":[73],"Oxaliplatin":[74],"85":[75],"mg/m2":[76,81,88],"biweekly":[77,82],"125":[80],"were":[83,114,152,171,217],"combined":[84],"cetuximab":[86,276],"400":[87],"loading":[89],"dose":[90],"subsequent":[92],"weekly":[93],"250":[94],"mg/m2.":[95],"13":[97],"months":[98],"40":[99],"histological":[102],"proven":[103],"unresectable":[104],"and/or":[105],"metastatic":[106,137],"adenocarcinoma":[108],"no":[110],"palliative":[112],"treated.":[115],"Median":[116],"age:":[117],"64":[118],"years":[119],"(range":[120],"20\u201380":[121],"years),":[122],"male/female":[123],"ratio:":[124],"24/16,":[125],"PS":[126,130],"0:":[127],"17":[128],"patients,":[129,140],"1/2:":[131],"22":[132,139],"(1":[134],"unknown),":[135],"single":[136],"site:":[138],"multiple":[141],"metastases:":[142],"18":[143],"patients.":[144],"Primary":[145],"endpoint":[146],"rate,":[149],"secondary":[150],"objectives":[151],"safety,":[153],"progression":[157],"free":[158],"time.":[160],"Results:":[161],"Frequently":[162],"reported":[163,253],"adverse":[164],"events":[165],"(more":[166],"than":[167],"20%":[168],"pts.)":[170],"predominantly":[172],"grade1":[173],"or":[174],"2":[175,234,240],"included":[177,197],"neutropenia":[178,198],"(41%":[179],"patients),":[181],"thrombocytopenia":[182],"(20%),":[183],"anemia":[184,202],"(65%),":[185],"nausea":[186,206],"(53%),":[187],"diarrhea":[188,211],"(63%),":[189],"alopecia":[190],"(15%).":[191],"Grade":[192],"3":[193,243],"4":[195],"toxicities":[196],"7/40":[200],"pts.,":[201,205,209,238],"4/40":[204],"2/40":[208],"5/40":[213],"pts.":[214,241],"14":[215],"taken":[218],"off-study":[219],"due":[220],"to":[221,293],"toxicity":[222,281],"(allergic":[223],"reaction,":[224],"n=2).":[225],"Sensory":[226],"neuropathy":[227],"occurred":[228],"mostly":[229],"as":[230],"grade":[231,242,250],"1":[232],"45%":[236],"neurotoxicity":[244],"observed.":[246],"Acneiform":[247],"skin":[248],"rash":[249],"1/2/3":[251],"30%/18%/8%":[255],"respectively.":[258],"First":[259],"efficacy":[260],"data":[261],"will":[262],"be":[263],"presented":[264],"at":[265],"the":[266,283],"meeting.":[267],"Conclusion:":[268],"The":[269],"feasible":[278],"shows":[280],"within":[282],"range":[284],"other":[286],"polychemotherapy":[287],"regimens.":[288],"No":[289],"significant":[290],"financial":[291],"relationships":[292],"disclose.":[294]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}